Geron reported 1.19M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Amgen USD 3.01B 406M Jun/2025
Bio Techne USD 118.15M 16.53M Jun/2025
Cassava Sciences 5.12M 5.02M Jun/2025
Cytokinetics 112.55M 12.71M Jun/2025
Exelixis USD 19.47M 298K Jul/2025
Genmab DKK 57M 15M Jun/2025
Geron 1.19M 16K Jun/2025
Gilead Sciences USD 1.5B 39M Jun/2025
Incyte USD 78.77M 10.96M Jun/2025
MacroGenics USD 49.7M 44.21M Jun/2025
Novartis USD 3.32B 95M Jun/2025